19578553|t|Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patients.
19578553|a|PURPOSE: To investigate the association between Apolipoprotein E (APOE), tumor suppressor protein p53 (p53), and cyclin-dependent kinase inhibitor 1A (p21) genes and primary open-angle glaucoma (POAG) in a cohort of Turkish subjects. METHODS: Seventy-five POAG patients (49 women, 26 men) and 119 healthy subjects (67 women, 52 men) were genotyped with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Allele and genotype frequencies between healthy subjects and glaucoma patients were compared by the chi(2) test, and intraocular pressure (IOP), cup/disc ratio (C/D) and visual field indices (MD and PSD) were compared among different APOE, p53, and p21 genotypes in POAG group. A p value <0.05 was considered as statistically significant. RESULTS: The mean ages were 63.8+/-9.5 and 61.8+/-10.2 years in POAG and control groups, respectively (p=0.18). There were no significant differences in the distribution of APOE, p53, and p21 genotypes between the healthy subjects and POAG patients (p=0.38, p=0.12, and p=0.2, respectively). There were no significant differences in maximum IOP, MD, and PSD values among different groups of p53 and p21 genotypes (p>0.05). POAG subjects with the epsilon2epsilon3 genotype had a worse PSD value (median=2.2) than those with the epsilon3epsilon4 genotype (median=1.77; p=0.01) and POAG subjects with the epsilon3epsilon3 genotype had worse MD and PSD values (median= -7.4 and 3.4, respectively) than those with the epsilon3epsilon4 genotype (median= -4.1 and 1.77, respectively; p=0.034 and 0.028, respectively). CONCLUSIONS: Our study found no link between polymorphisms in APOE, p53, and p21 genes and POAG in Turkish patients, although a larger sample is required to elucidate the role of these polymorphisms in the pathogenesis and course of glaucoma.
19578553	32	36	APOE	Gene	348
19578553	38	41	p53	Gene	7157
19578553	47	50	p21	Gene	1026
19578553	56	83	primary open-angle glaucoma	Disease	MESH:D005902
19578553	95	103	patients	Species	9606
19578553	153	169	Apolipoprotein E	Gene	348
19578553	171	175	APOE	Gene	348
19578553	203	206	p53	Gene	7157
19578553	208	211	p53	Gene	7157
19578553	218	254	cyclin-dependent kinase inhibitor 1A	Gene	1026
19578553	256	259	p21	Gene	1026
19578553	271	298	primary open-angle glaucoma	Disease	MESH:D005902
19578553	300	304	POAG	Disease	MESH:D005902
19578553	361	365	POAG	Disease	MESH:D005902
19578553	366	374	patients	Species	9606
19578553	379	384	women	Species	9606
19578553	389	392	men	Species	9606
19578553	423	428	women	Species	9606
19578553	433	436	men	Species	9606
19578553	598	606	glaucoma	Disease	MESH:D005901
19578553	607	615	patients	Species	9606
19578553	771	775	APOE	Gene	348
19578553	777	780	p53	Gene	7157
19578553	786	789	p21	Gene	1026
19578553	803	807	POAG	Disease	MESH:D005902
19578553	940	944	POAG	Disease	MESH:D005902
19578553	1049	1053	APOE	Gene	348
19578553	1055	1058	p53	Gene	7157
19578553	1064	1067	p21	Gene	1026
19578553	1111	1115	POAG	Disease	MESH:D005902
19578553	1116	1124	patients	Species	9606
19578553	1267	1270	p53	Gene	7157
19578553	1275	1278	p21	Gene	1026
19578553	1299	1303	POAG	Disease	MESH:D005902
19578553	1455	1459	POAG	Disease	MESH:D005902
19578553	1749	1753	APOE	Gene	348
19578553	1755	1758	p53	Gene	7157
19578553	1764	1767	p21	Gene	1026
19578553	1778	1782	POAG	Disease	MESH:D005902
19578553	1794	1802	patients	Species	9606
19578553	1920	1928	glaucoma	Disease	MESH:D005901
19578553	Association	MESH:D005902	1026
19578553	Association	MESH:D005902	7157
19578553	Association	MESH:D005902	348

